May 21, 2025
Preclinical models that accurately predict clinical outcomes are vital for advancing cancer therapeutics. Patient-Derived Xenograft (PDX) models—created by implanting human tumor fragments into immunodeficient mice—maintain the architecture, stromal elements, and molecular heterogeneity of the original tumor. They’re essential for testing new drugs, understanding resistance, and discovering predictive biomarkers. What Are […]